BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24716976)

  • 1. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells.
    Chen HM; Zhang DG; Wu JX; Pei DS; Zheng JN
    Asian Pac J Cancer Prev; 2014; 15(5):2313-8. PubMed ID: 24716976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.
    Nagamine M; Okumura T; Tanno S; Sawamukai M; Motomura W; Takahashi N; Kohgo Y
    Cancer Sci; 2003 Apr; 94(4):338-43. PubMed ID: 12824901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
    Baek SJ; Wilson LC; Hsi LC; Eling TE
    J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
    Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
    World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
    Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC
    Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
    Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS
    World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
    Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
    Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J; Cooper SK; Phang JM
    J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO; Stewart LV
    Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
    Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.
    Colin-Cassin C; Yao X; Cerella C; Chbicheb S; Kuntz S; Mazerbourg S; Boisbrun M; Chapleur Y; Diederich M; Flament S; Grillier-Vuissoz I
    Mol Carcinog; 2015 May; 54(5):393-404. PubMed ID: 24293218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects.
    Pseftogas A; Gonidas C; Mosialos G
    Int J Biochem Cell Biol; 2017 Jan; 82():49-56. PubMed ID: 27865894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.